RegentAtlantic Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $11.3M | Sell |
118,181
-1,553
| -1% | -$154K | 0.34% | 47 |
|
|
2022
Q2 | $11.1M | Buy |
119,734
+1,161
| +1% | +$113K | 0.37% | 46 |
|
|
2022
Q1 | $12M | Sell |
118,573
-1,421
| -1% | -$149K | 0.34% | 53 |
|
|
2021
Q4 | $12.4M | Buy |
119,994
+4,672
| +4% | +$432K | 0.35% | 50 |
|
|
2021
Q3 | $9.79M | Sell |
115,322
-2,960
| -3% | -$248K | 0.3% | 58 |
|
|
2021
Q2 | $9.87M | Buy |
118,282
+55
| +0% | +$4.5K | 0.3% | 57 |
|
|
2021
Q1 | $8.89M | Sell |
118,227
-2,351
| -2% | -$171K | 0.3% | 62 |
|
|
2020
Q4 | $8.23M | Sell |
120,578
-6,076
| -5% | -$395K | 0.33% | 59 |
|
|
2020
Q3 | $7.4M | Sell |
126,654
-6,992
| -5% | -$435K | 0.33% | 64 |
|
|
2020
Q2 | $8.68M | Buy |
133,646
+6,978
| +6% | +$439K | 0.48% | 45 |
|
|
2020
Q1 | $7.51M | Buy |
126,668
+36,223
| +40% | +$2.42M | 0.59% | 44 |
|
|
2019
Q4 | $6.72M | Sell |
90,445
-3,242
| -3% | -$228K | 0.41% | 67 |
|
|
2019
Q3 | $5.91M | Sell |
93,687
-8,246
| -8% | -$489K | 0.39% | 67 |
|
|
2019
Q2 | $5.55M | Sell |
101,933
-25,942
| -20% | -$1.4M | 0.37% | 72 |
|
|
2019
Q1 | $6.9M | Sell |
127,875
-78,983
| -38% | -$4.87M | 0.48% | 55 |
|
|
2018
Q4 | $13.6M | Buy |
206,858
+42,271
| +26% | +$3.16M | 1.15% | 15 |
|
|
2018
Q3 | $13M | Buy |
164,587
+1,999
| +1% | +$143K | 0.99% | 23 |
|
|
2018
Q2 | $10.5M | Buy |
162,588
+12,230
| +8% | +$806K | 0.9% | 27 |
|
|
2018
Q1 | $9.35M | Sell |
150,358
-742
| -0.5% | -$53.2K | 0.78% | 40 |
|
|
2017
Q4 | $11M | Buy |
151,100
+312
| +0.2% | +$22.7K | 0.9% | 32 |
|
|
2017
Q3 | $12.3M | Sell |
150,788
-1,201
| -0.8% | -$95K | 1.06% | 22 |
|
|
2017
Q2 | $12.2M | Sell |
151,989
-464
| -0.3% | -$36.6K | 1.11% | 20 |
|
|
2017
Q1 | $12M | Sell |
152,453
-657
| -0.4% | -$52.5K | 1.11% | 19 |
|
|
2016
Q4 | $12.1M | Sell |
153,110
-1,313
| -0.9% | -$106K | 1.18% | 16 |
|
|
2016
Q3 | $13.7M | Sell |
154,423
-2,755
| -2% | -$260K | 1.42% | 10 |
|
|
2016
Q2 | $15M | Sell |
157,178
-8,534
| -5% | -$851K | 1.45% | 9 |
|
|
2016
Q1 | $17.2M | Sell |
165,712
-4,800
| -3% | -$467K | 1.89% | 3 |
|
|
2015
Q4 | $16.7M | Sell |
170,512
-6,864
| -4% | -$672K | 1.78% | 4 |
|
|
2015
Q3 | $17.1M | Sell |
177,376
-14,027
| -7% | -$1.47M | 1.65% | 5 |
|
|
2015
Q2 | $20.1M | Sell |
191,403
-5,809
| -3% | -$594K | 1.79% | 5 |
|
|
2015
Q1 | $20.4M | Sell |
197,212
-13,312
| -6% | -$1.35M | 1.78% | 5 |
|
|
2014
Q4 | $20.3M | Sell |
210,524
-9,108
| -4% | -$803K | 1.71% | 5 |
|
|
2014
Q3 | $17.5M | Sell |
219,632
-1,587
| -0.7% | -$125K | 1.63% | 6 |
|
|
2014
Q2 | $16.7M | Sell |
221,219
-2,207
| -1% | -$167K | 1.55% | 7 |
|
|
2014
Q1 | $16.7M | Sell |
223,426
-7,804
| -3% | -$551K | 1.63% | 5 |
|
|
2013
Q4 | $16.5M | Buy |
231,230
+1,812
| +0.8% | +$116K | 1.6% | 6 |
|
|
2013
Q3 | $13M | Buy |
229,418
+2,267
| +1% | +$135K | 1.42% | 8 |
|
|
2013
Q2 | $13M | Buy |
+227,151
| New | +$13.2M | 1.54% | 6 |
|
Other funds holding CVS
RegentAtlantic Capital's CVS Position: Q3 2022 in Review
RegentAtlantic Capital reduced its CVS Health (CVS) stake by 1.3% in Q3 2022, selling an estimated $154K and leaving 118,181 shares worth $11.3M. The position accounts for 0.34% of the portfolio, ranked #47.
RegentAtlantic Capital first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $20.4M in Q1 2015. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- RegentAtlantic Capital held 118,181 shares of CVS Health worth $11.3M as of Q3 2022.
- RegentAtlantic Capital sold 1,553 CVS Health shares in Q3 2022, an estimated $154K.
- CVS Health made up 0.34% of RegentAtlantic Capital's portfolio in Q3 2022, its #47 holding.
- RegentAtlantic Capital first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's CVS Health position peaked at $20.4M in Q1 2015.
- 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.